Table 5.

Impacts on program components, excluding controls for baseline characteristics but including controls for randomization strata (percent, unless otherwise noted)

Program component	Treatment mean	Control mean	Impact	p-Value	Adjusted p-value	Sample size
In previous 12 months, exposed to information on
Relationships	20.33	18.54	1.80	0.737	1.000	221
Parenting	64.67	45.73	18.94	0.005	0.027	220
Child health care	53.93	55.61	− 1.68	0.803	1.000	221
Education related services	27.69	30.55	− 2.86	0.643	0.997	220
Career Counseling or job training	17.05	23.98	− 6.93	0.208	0.730	220
Methods of birth control	80.04	70.05	9.99	0.092	0.416	217
Percent correct on assessments of knowledge of contraception
Condoms	59.58	60.31	− 0.73	0.826	0.999	220
Birth control pills	47.98	53.26	− 5.28	0.183	0.504	220
IUDs	36.70	33.46	3.24	0.357	0.790	220
Other methods	37.02	36.75	0.27	0.939	1.000	220

Treatment and control group means are regression adjusted. Impacts on binary outcomes are estimated using the linear probability model, with standard errors adjusted to account for heteroskedasticity. Regressions control only for treatment status and randomization stratum. All p-values are based on a two-sided test, and adjusted p-values control for the familywise error rate using the method in Hothorn et al. (2008). Sample sizes differ across outcomes due to missing outcome data. Source: Baseline survey and 12 month follow-up survey

^*Significantly different from zero at the .10 level after adjusting for multiple comparisons, two-tailed test

^**Significantly different from zero at the .05 level after adjusting for multiple comparisons, two-tailed test

^***Significantly different from zero at the .01 level after adjusting for multiple comparisons, two-tailed test